BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 10, 2002
View Archived Issues
Santarus Partners Technology With TAP In Potential $100M Deal
Santarus Inc. stands to gain up to $100 million through a licensing agreement announced Tuesday with TAP Pharmaceutical Products Inc. aimed at developing a next-generation therapy for upper gastrointestinal diseases. (BioWorld Today)
Read More
Elan Seeking US$1B In Asset Sale As Top Executive Departs
Read More
Staphylococcus aureus Finally Outlasted Vancomycin, But New Antibiotics Are Treating Patient
Read More
Micrologix Signs MBI 226 Deal With Fujisawa For Up To $21M
Read More
Other News To Note
Read More
AIDS Conference
Read More